
Fundamental analysis calculates a security's intrinsic value by evaluating macroeconomic, industry, and company-specific financial data. Unlike technical analysis, this long-term strategy identifies mispriced assets based on underlying business health, though it demands significant research, reliable data, and patience

Challenger (ASX: CGF) delivers disciplined growth and capital strength, positioning itself as Australia’s leading retirement‑income compounder with expanding annuity sales, resilient margins and a robust balance sheet.

Manuka Resources is retracing after its May rally as investors await production milestones. With gold processing expected in July and silver production targeted for September, the market is looking for operational results to confirm the company's restart strategy.

Inoviq shares plunged after sample-quality issues delayed validation of its EXO-OC ovarian cancer test, despite improved algorithm performance. The sharp reversal has shifted investor focus from growth potential to execution risks, timelines, and confidence in the company’s development strategy.

Macquarie Group (ASX: MQG) delivers muscular earnings growth, disciplined capital management and diversified global momentum, positioning itself as Australia’s premier financial powerhouse with sustainable mid‑teen returns and expanding shareholder value.

QBE Insurance Group (ASX: QBE) delivers disciplined underwriting, robust investment returns and rising capital returns, offering high-conviction, income-led exposure to global commercial insurance with upside from sustained double-digit ROE and capital-efficient growth.